Powerful immune cells able to recognise Omicron, study suggests
T cells are a type of white blood cell that hunt down and destroy infected cells in the body.
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Powerful immune cells that are thought to play a role in long-term protection from serious Covid-19 are able to recognise Omicron, a new study has found.
T cells are a type of white blood cell that hunt down and destroy infected cells in the body, and the new research shows that, despite extensive mutations, they are able to recognise the Omicron variant.
Omicron is already known to evade the body’s antibody forces, but until now experts have been unsure about the role of T cells in relation to the variant.
Previous studies have found that T cells, which can be made in response to vaccines and/or infection, may play a vital role in preventing people getting seriously ill with Covid-19.
Catherine Riou and Wendy Burgers, along with colleagues from the University of Cape Town South Africa examined T cell responses in people who had previously been vaccinated or infected with earlier variants of the virus.
The authors examined the T cell response from 40 people who had received either one or two doses of the Johnson & Johnson vaccine, 15 who had received two doses of the Pfizer BioNTech jab, and 15 unvaccinated people who had had previous infection.
They found that 70% to 80% of T cell responses were maintained against the Omicron spike protein across the study groups.
For 19 patients who were admitted to hospital with Omicron in South Africa – where the variant was first detected – the authors found that these people had T cell responses comparable to those seen in patients who were admitted to hospital in previous waves of the pandemic, when the Beta and Delta variants were dominant.
Writing in the journal Nature, the authors said: “Despite Omicron’s extensive mutations and reduced susceptibility to neutralising antibodies, the majority of T cell responses, induced by vaccination or infection, cross-recognise the variant.
“It remains to be determined whether well-preserved T cell immunity to Omicron contributes to protection from severe Covid-19, and is linked to early clinical observations from South Africa and elsewhere.”
A separate study published in the same journal found that T cell responses induced by vaccination are well conserved against the Omicron variant.
Penny Ward is an independent pharmaceutical physician, and visiting professor in pharmaceutical medicine at King’s College London.
She said: “These data offer at least one explanation for the observed retained protection against severe disease following reinfection in vaccinated patients during the recent Omicron wave, and offer at least some reassurance that these broad responses may also blunt disease severity should, as expected, further variants emerge.”
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.